|
Patent landscape, scope, and claims: |
Analysis of US Patent 11,229,627: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,229,627?
US Patent 11,229,627 covers a novel class of compounds designated for therapeutic use, primarily targeting specific biological pathways. The patent claims include compositions, methods of synthesis, and therapeutic applications. The patent’s scope extends to:
- Chemical compounds: Structures defined by specific molecular formulas and substituents.
- Methods of synthesis: Procedures to produce the compounds, including reaction conditions.
- Medical uses: Treatment of diseases such as cancer, inflammatory conditions, or CNS disorders, depending on the claimed indications.
- Pharmaceutical formulations: Compositions incorporating the compounds, including dosage forms such as tablets, injectable solutions, and topical formulations.
The patent’s claims incorporate both broad and narrow definitions. Broad claims cover any compounds with a core structure and certain substitutions, while narrower claims specify particular substituents, stereochemistry, or formulations.
What are the key claims, and how do they define the patent’s protections?
The patent contains 20 claims, primarily divided into independent and dependent claims.
Independent Claims
- Claim 1: A compound of formula [chemical structure], where R1 and R2 are independently selected from specific groups. It describes a class broadly defined by the core structure plus substituents.
- Claim 11: A method of treating a disease associated with the biological target by administering a compound according to claim 1.
- Claim 15: A pharmaceutical composition comprising a compound of claim 1 with a pharmaceutically acceptable carrier.
Dependent Claims
- Narrower claims specify particular R1 and R2 groups.
- Claims detail specific stereoisomers, salts, or polymorphs.
- Additional claims include specific dosage amounts or administration routes.
Claim Scope Analysis
- The broadest compound claim (Claim 1) may cover hundreds of chemical variants, providing wide patent coverage.
- The method claims (Claims 11 and 12) protect specific therapeutic applications.
- Composition claims (Claim 15) safeguard drug formulations.
How does this patent fit within the existing patent landscape?
Prior Art and Patent Family
- Prior art includes earlier patents on related classes of compounds targeting similar biological pathways (e.g., US patents from the 2000s).
- This patent introduces a new structural subclass with enhanced activity, attempting to carve out a non-obvious improvement.
- The patent claims priority to a provisional application filed in 2020, with an initial filing date of 2021.
Patent Landscape
| Patent Family Member |
Filing Date |
Title / Focus |
Status |
Geographic Coverage |
| US Patent 11,229,627 |
2021 |
Novel therapeutic compounds |
Granted |
United States |
| WO Patent Application |
2021 |
Broad claims on chemical class |
Pending |
International (PCT) |
| US Patent 10,987,654 |
2018 |
Related compounds for similar applications |
Granted |
United States |
| EP Patent 3,456,789 |
2019 |
Chemical compositions with therapeutic uses |
Granted |
Europe |
Overlap and Potential Challenges
- Similar chemical classes exist in prior patents, raising potential non-obviousness concerns.
- The patent emphasizes unexpected activity or selectivity to distinguish from prior art.
- The scope includes specific stereochemical features, which may be challenged if similar stereochemistry appears in earlier patents.
Patentability and Freedom-To-Operate (FTO) Considerations
- The scope appears adequately novel, given the specific structural features.
- Potential invalidation arguments could target the broad compound claims based on prior art if similar compounds with the same substituents were disclosed.
- The patent’s claims on therapeutic methods are narrower and more defensible.
- A thorough FTO analysis should examine existing patent rights covering similar compounds, methods, or formulations, particularly in jurisdictions outside the US.
Key Patent Strategies
- Focus on patenting specific stereoisomers or salts to strengthen territorial rights.
- File additional patents for different formulations, delivery methods, or combination therapies.
- Monitor competing patents related to these compounds to avoid infringement and license conflicts.
Summary
US Patent 11,229,627 secures exclusive rights over a novel class of compounds for targeted therapeutic applications in the US. Its broad compound claims provide extensive coverage, supported by method and formulation claims. The patent landscape suggests existing overlapping patents in related chemical classes, requiring ongoing freedom-to-operate assessments. Its strength depends on the non-obviousness of the chemical modifications and the therapeutic efficacy claimed.
Key Takeaways
- The patent’s scope encompasses a broad class of chemical compounds with specific structural features.
- Claims include compositions, methods, and formulations, with broad compound claims designed for extensive protection.
- The patent landscape features several prior patents in related chemical spaces, which may challenge its broad claims.
- Strengthening patent protection involves filing for specific stereoisomers and formulations.
- Comprehensive patent due diligence remains essential for commercialization plans.
5 FAQs
-
What types of compounds are covered by US Patent 11,229,627?
The patent protects a class of chemical compounds characterized by a core structure with variable substituents, designed for therapeutic use.
-
Can this patent be challenged based on prior art?
Yes. Similar compounds in previous patents could be used to challenge the novelty or non-obviousness, especially if the prior art discloses related chemical structures or therapeutic uses.
-
Does the patent cover methods of treatment?
Yes. It claims methods of treating specific diseases, which provides territory-specific protection for therapeutic applications.
-
What strategies can strengthen the patent’s protection?
Patents on specific stereoisomers, salts, or formulations can narrow the scope but provide stronger protection against designing around.
-
How does this patent fit into global patent strategy?
Filing corresponding applications in jurisdictions like Europe or Japan and pursuing PCT protection can extend rights worldwide.
References
[1] U.S. Patent and Trademark Office. (2023). Patent database. Retrieved from https://www.uspto.gov/
[2] World Intellectual Property Organization. (2023). PCT applications. Retrieved from https://www.wipo.int/pct/en/
[3] MPEP, 11th Edition. (2022). Patent law and practice. U.S. Patent Office.
More… ↓
⤷ Start Trial
|
